Northwest Biotherapeutics | NWBO - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Agenus USD 82.99M 2.3M 2025-12
AstraZeneca USD 25.28B 252M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Celldex Therapeutics USD 1.18M 3.09M 2025-12
Eisai JPY 85.49B 4.76B 2025-12
Infinity Pharmaceuticals USD 1.5M 433K 2023-06
Merck USD 4.15B 102M 2025-09
Northwest Biotherapeutics 36.72M 9.49M 2025-09
Pfizer USD 5.02B 142M 2025-09
Plus Therapeutics 5.92M 5.7M 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12